Cancer-related fatigue and chemotherapy-associated adverse effects: Correlation with TNF-α, IL-1 and 17-hydroxycorticosteroids

Future Oncology

Volumn 10, Issue 9, 2014, Pages 1619-1626

  Zhang, Shuyao ^a   Zeng, De ^a   Peng, Yuhui ^a   Yang, Yuxian ^a   Zhuang, Xiaowen ^a   Li, Zongtai ^a,b   Wang, Miaojun ^a   Chen, Lei ^a   Zhang, Hao ^a,b  

^a CANCER HOSPITAL OF SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

^b SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

17 HCS; 17 hydroxycorticosteroids; cancer related fatigue; IL 1; TNF

Indexed keywords

17 HYDROXYCORTICOSTEROID; ANTINEOPLASTIC AGENT; BLEOMYCIN; CAPECITABINE; CISPLATIN; CYCLOPHOSPHAMIDE; DACARBAZINE; DOCETAXEL; DOXORUBICIN; FLUOROURACIL; INTERLEUKIN 1; METHOTREXATE; OXALIPLATIN; PACLITAXEL; PREDNISONE; TUMOR NECROSIS FACTOR ALPHA; VINCRISTINE; VINCRISTINE SULFATE; TNF PROTEIN, HUMAN; TUMOR MARKER;

ADOLESCENT; ADULT; ADVERSE OUTCOME; AGED; ARTICLE; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER FATIGUE; CANCER PATIENT; CHEMOTHERAPY ASSOCIATED ADVERSE EFFECT; DRUG INDUCED DISEASE; DYSPNEA; ESOPHAGUS CANCER; FEMALE; HEART PALPITATION; HODGKIN DISEASE; HORMONE URINE LEVEL; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; NASOPHARYNX CARCINOMA; NONHODGKIN LYMPHOMA; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RASH; STOMACH CANCER; UTERINE CERVIX CANCER; VERY ELDERLY; BLOOD; COMPLICATION; FATIGUE; MIDDLE AGED; NEOPLASMS; URINE; YOUNG ADULT;

17-HYDROXYCORTICOSTEROIDS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; FATIGUE; FEMALE; HUMANS; INTERLEUKIN-1; MALE; MIDDLE AGED; NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84906541989     PISSN: 14796694     EISSN: 17448301     Source Type: Journal    
DOI: 10.2217/fon.14.15     Document Type: Article

References (22)

1. Radbruch L, Strasser F, Elsner F et al. Fatigue in palliative care patients - an EAPC approach. Palliat. Med. 22(1), 13-32 (2008
2. Kamath J. Cancer-related fatigue, inflammation and thyrotropin-releasing hormone. Curr Aging Sci. 5(3), 195-202 (2012
3. Roscoe JA, Kaufman ME, Matteson-Rusby SE et al. Cancer-related fatigue and sleep disorders. Oncologist 12(Suppl. 1), 35-42 (2007
4. Stasi R, Abriani L, Beccaglia P, Terzoli E, Amadori S. Cancer-related fatigue: evolving concepts in evaluation and treatment. Cancer 98(9), 1786-1801 (2003
5. Hofman M, Ryan JL, Figueroa-Moseley CD, Jean-Pierre P, Morrow GR. Cancer-related fatigue: the scale of the problem. Oncologist 12(Suppl. 1), 4-10 (2007
6. Forlenza MJ, Hall P, Lichtenstein P, Evengard B, Sullivan PF. Epidemiology of cancer-related fatigue in the Swedish twin registry. Cancer 104(9), 2022-2031 (2005
7. Ahlberg K, Ekman T, Gaston-Johansson F, Mock V. Assessment and management of cancer-related fatigue in adults. Lancet 362(9384), 640-650 (2003
8. Cleeland CS. Cancer-related fatigue: new directions for research. Introduction. Cancer 92(6 Suppl.), 1657-1661 (2001
9. de Raaf PJ, Sleijfer S, Lamers CH, Jager A, Gratama JW, van der Rijt CC. Inflammation and fatigue dimensions in advanced cancer patients and cancer survivors: an explorative study. Cancer 118(23), 6005-6011 (2012
10. Barnes EA, Bruera E. Fatigue in patients with advanced cancer: a review. Int. J. Gynecol. Cancer 12(5), 424-428 (2002
11. Goldstein D, Bennett B, Friedlander M, Davenport T, Hickie I, Lloyd A. Fatigue states after cancer treatment occur both in association with, and independent of, mood disorder: a longitudinal study. BMC Cancer 6, 240 (2006
12. Moss RB, Mercandetti A, Vojdani A. TNF-alpha and chronic fatigue syndrome. J. Clin. Immunol. 19(5), 314-316 (1999
13. Liu L, Mills PJ, Rissling M et al. Fatigue and sleep quality are associated with changes in inflammatory markers in breast cancer patients undergoing chemotherapy. Brain Behav. Immun. 26(5), 706-713 (2012
14. Okuyama T, Akechi T, Kuyama A, Okamura H, Shima Y, Maruguchi M, Hosaka T, Uchitomi Y. Development and validation of the cancer fatigue scale: a brief, three-dimensional, self-rating scale for assessment of fatigue in cancer patients. J. Pain Symptom Manage. 19(1), 5-14 (2000
15. Lundstrom S, Furst CJ. Symptoms in advanced cancer: relationship to endogenous cortisol levels. Palliat. Med. 17(6), 503-508 (2003
16. de C Williams AC, Davies HT, Chadury Y. Simple pain rating scales hide complex idiosyncratic meanings. Pain 85, 457-463 (2000
17. Prue G, Rankin J, Allen J, Gracey J, Cramp F. Cancer-related fatigue: a critical appraisal. Eur. J. Cancer 42(7), 846-863 (2006
18. Bower JE, Ganz PA, Desmond KA et al. Fatigue in long-term breast carcinoma survivors: a longitudinal investigation. Cancer 106(4), 751-758 (2006
19. Orre IJ, Fossa SD, Murison R et al. Chronic cancer-related fatigue in long-term survivors of testicular cancer. J. Psychosom. Res. 64(4), 363-371 (2008
20. Curt GA, Breitbart W, Cella D et al. Impact of cancer-related fatigue on the lives of patients: new findings from the Fatigue Coalition. Oncologist 5(5), 353-360 (2000
21. Schubert C, Hong S, Natarajan L, Mills PJ, Dimsdale JE. The association between fatigue and inflammatory marker levels in cancer patients: a quantitative review. Brain Behav. Immun. 21(4), 413-427 (2007
22. Moss RB, Mercandetti A, Vojdani A. TNF-alpha and chronic fatigue syndrome. J. Clin. Immunol. 19(5), 314-316 (1999).